DekaBank Deutsche Girozentrale
FOMX

DekaBank Deutsche Girozentrale’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-13,000
Closed -$85K – 1078
2016
Q1 		$85K Buy
+13,000
New +$83.8K ﹤0.01% 985

Other funds holding FOMX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

DekaBank Deutsche Girozentrale's FOMX Position: Q2 2016 in Review

DekaBank Deutsche Girozentrale sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q2 2016, closing a stake of 13,000 shares — an estimated $85K sold.

DekaBank Deutsche Girozentrale first reported a position in FOMX in Q1 2016 and held it in 1 quarter. The position peaked at $85K in Q1 2016. 56 funds tracked by Wall St. Rank hold FOMX as of Q2 2016.

  • DekaBank Deutsche Girozentrale reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q2 2016 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 13,000 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q2 2016, an estimated $85K.
  • DekaBank Deutsche Girozentrale first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q1 2016 and held it in 1 quarter.
  • DekaBank Deutsche Girozentrale's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $85K in Q1 2016.
  • 56 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q2 2016.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2016, filed 4 Aug 2016.